Back to Search
Start Over
Prevention and treatment of cancer-related infections.
- Source :
-
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2012 Nov 01; Vol. 10 (11), pp. 1412-45. - Publication Year :
- 2012
-
Abstract
- Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections provide an overview of the risk factors for infectious complications, recommendations for infectious risk categorization, and strategies for prevention of infections in high-risk patient populations with cancer. Individualized risk evaluation for infections and incorporation of preventative measures are essential components of the overall spectrum of cancer care, and may contribute to optimizing treatment outcomes for patients.
- Subjects :
- Anti-Bacterial Agents therapeutic use
Antifungal Agents therapeutic use
Antineoplastic Agents adverse effects
Antineoplastic Agents therapeutic use
Antiviral Agents therapeutic use
Bacterial Infections etiology
Bacterial Infections immunology
Bacterial Infections therapy
Hematopoietic Stem Cell Transplantation
Humans
Mycoses etiology
Mycoses immunology
Mycoses therapy
Neoplasms drug therapy
Neoplasms immunology
Neutropenia chemically induced
Neutropenia complications
Risk Factors
Virus Diseases etiology
Virus Diseases immunology
Virus Diseases therapy
Bacterial Infections prevention & control
Immunocompromised Host
Mycoses prevention & control
Neoplasms complications
Virus Diseases prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1540-1413
- Volume :
- 10
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Journal of the National Comprehensive Cancer Network : JNCCN
- Publication Type :
- Academic Journal
- Accession number :
- 23138169
- Full Text :
- https://doi.org/10.6004/jnccn.2012.0146